Brief: Vita Life Sciences Says HY Revenue Up 27.3% To A$32.7 Mln

Vita Life Sciences

26/08/2022 11:26

Aug 26 (Reuters) - Vita Life Sciences Ltd  VLS.AX :
    * HY REVENUE UP 27.3% TO A$32.7 MILLION
    * HY NET PROFIT ATTRIBUTABLE A$3.6 MILLION VERSUS A$3.7
MILLION
    * DECLARED FULLY FRANKED INTERIM DIVIDEND OF 2.75 AU CENTS
PER
ORDINARY SHARE

Source text for Eikon:  ID:nASX6G2kKs 
Further company coverage:  VLS.AX